Dr. Leslie Saltzman of Labcorp discusses the Marker Genetic Health Panel, who may benefit from hereditary genetic testing, and how it can provide insight into inherited health risks.
A new diagnostic test may offer little value if it’s simply added to an existing protocol. Explore how Texas Health Presbyterian Hospital Denton redesigned its sepsis workflow around a rapid host-response test—and what the experience means for other laboratories.
Revvity has unveiled the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified multiplex assay designed for early detection of type 1 diabetes risk in children through simple blood spot samples, supporting national screening programs.
Earn CE credit on Oct. 20 while learning how to implement full-process quality control in clinical flow cytometry. This live webinar reviews regulatory requirements, consensus standards, and practical approaches for monitoring pre-analytic and analytic variables that can affect patient results.
